Literature DB >> 25341078

Bilateral diffusion-weighted MR imaging of breast tumors with submillimeter resolution using readout-segmented echo-planar imaging at 7 T.

Wolfgang Bogner1, Katja Pinker, Olgica Zaric, Pascal Baltzer, Lenka Minarikova, David Porter, Zsuzsanna Bago-Horvath, Peter Dubsky, Thomas H Helbich, Siegfried Trattnig, Stephan Gruber.   

Abstract

PURPOSE: To evaluate the image quality, robustness, and diagnostic performance of submillimeter in-plane resolution diffusion-weighted ( DW diffusion-weighted ) magnetic resonance (MR) imaging at 7 T in the assessment of breast tumors.
MATERIALS AND METHODS: Institutional review board approval and written informed consent of five volunteers and 33 patients with 33 breast lesions (31 with histopathologic confirmation, two with confirmation at follow-up) were obtained. Image quality optimization and comparisons of readout-segmented echo-planar imaging ( rs-EPI readout-segmented echo-planar imaging ) and single-shot echo-planar imaging ( ss-EPI single-shot echo-planar imaging ) with or without parallel imaging were performed in volunteers. In all patients, bilateral DW diffusion-weighted imaging was performed in 3 minutes 35 seconds by using combined rs-EPI readout-segmented echo-planar imaging and parallel imaging with 0.9 × 0.9 mm in-plane resolution with a 7-T whole-body MR imager. Image quality, lesion conspicuity, and image properties (ie, signal-to-noise ratio, contrast-to-noise ratio) were assessed. Regions of interest were drawn in the largest lesion in each patient (23 malignant lesions, 10 benign lesions) by two independent readers. Apparent diffusion coefficient ( ADC apparent diffusion coefficient ) values were used to differentiate between benign and malignant breast tumors.
RESULTS: DW diffusion-weighted imaging with combined parallel imaging and rs-EPI readout-segmented echo-planar imaging reduced artifacts (ie, blurring and geometric distortions) by a calculated factor of seven when compared with DW diffusion-weighted imaging with ss-EPI single-shot echo-planar imaging , and it improved image quality from a score of 1 of 10 to a score of 8 of 10. The rs-EPI readout-segmented echo-planar imaging sequence with a b value of 0 sec/mm(2) yielded high-spatial-resolution T2-weighted MR images. An ADC apparent diffusion coefficient threshold of 1.275 × 10(-3) mm(2)/sec enabled differentiation between benign and malignant breast lesions, with sensitivity and specificity of 96% and 100%, respectively, for both independent readers.
CONCLUSION: At 7 T, one DW diffusion-weighted imaging examination of less than 4 minutes yielded high-quality ADC apparent diffusion coefficient maps and high-spatial-resolution T2-weighted MR images that were used to assess tumor and breast morphology. ADC apparent diffusion coefficient quantification alone enabled excellent differentiation of benign and malignant breast lesions.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25341078     DOI: 10.1148/radiol.14132340

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  20 in total

1.  Diffusion-Weighted Imaging-guided MR Spectroscopy in Breast Lesions using Readout-Segmented Echo-Planar Imaging.

Authors:  Kun Sun; Weimin Chai; Caixia Fu; Ying Zhan; Kunwei Shen; Xianfu Luo; Fuhua Yan
Journal:  Eur Radiol       Date:  2015-09-19       Impact factor: 5.315

2.  Diffusion-weighted imaging of breast tumours at 3 Tesla and 7 Tesla: a comparison.

Authors:  S Gruber; L Minarikova; K Pinker; O Zaric; M Chmelik; B Strasser; P Baltzer; T Helbich; S Trattnig; W Bogner
Journal:  Eur Radiol       Date:  2015-08-27       Impact factor: 5.315

3.  A 32-channel receive array coil for bilateral breast imaging and spectroscopy at 7T.

Authors:  Romina Del Bosque; Jiaming Cui; Stephen Ogier; Sergey Cheshkov; Ivan E Dimitrov; Craig Malloy; Steven M Wright; Mary McDougall
Journal:  Magn Reson Med       Date:  2020-08-09       Impact factor: 4.668

Review 4.  Proton MR spectroscopy in the breast: Technical innovations and clinical applications.

Authors:  Reza Fardanesh; Maria Adele Marino; Daly Avendano; Doris Leithner; Katja Pinker; Sunitha B Thakur
Journal:  J Magn Reson Imaging       Date:  2019-03-07       Impact factor: 4.813

Review 5.  Clinical role of breast MRI now and going forward.

Authors:  D Leithner; G J Wengert; T H Helbich; S Thakur; R E Ochoa-Albiztegui; E A Morris; K Pinker
Journal:  Clin Radiol       Date:  2017-12-09       Impact factor: 2.350

6.  Machine learning-based analysis of MR radiomics can help to improve the diagnostic performance of PI-RADS v2 in clinically relevant prostate cancer.

Authors:  Jing Wang; Chen-Jiang Wu; Mei-Ling Bao; Jing Zhang; Xiao-Ning Wang; Yu-Dong Zhang
Journal:  Eur Radiol       Date:  2017-04-03       Impact factor: 5.315

7.  Diffusion-weighted imaging of breast lesions: Region-of-interest placement and different ADC parameters influence apparent diffusion coefficient values.

Authors:  Hubert Bickel; Katja Pinker; Stephan Polanec; Heinrich Magometschnigg; Georg Wengert; Claudio Spick; Wolfgang Bogner; Zsuzsanna Bago-Horvath; Thomas H Helbich; Pascal Baltzer
Journal:  Eur Radiol       Date:  2016-08-30       Impact factor: 5.315

Review 8.  Diffusion-weighted breast MRI: Clinical applications and emerging techniques.

Authors:  Savannah C Partridge; Noam Nissan; Habib Rahbar; Averi E Kitsch; Eric E Sigmund
Journal:  J Magn Reson Imaging       Date:  2016-09-30       Impact factor: 4.813

Review 9.  Multiparametric MR Imaging of Breast Cancer.

Authors:  Habib Rahbar; Savannah C Partridge
Journal:  Magn Reson Imaging Clin N Am       Date:  2016-02       Impact factor: 2.266

10.  Potential of Noncontrast Magnetic Resonance Imaging With Diffusion-Weighted Imaging in Characterization of Breast Lesions: Intraindividual Comparison With Dynamic Contrast-Enhanced Magnetic Resonance Imaging.

Authors:  Pascal A T Baltzer; Hubert Bickel; Claudio Spick; Georg Wengert; Ramona Woitek; Panagiotis Kapetas; Paola Clauser; Thomas H Helbich; Katja Pinker
Journal:  Invest Radiol       Date:  2018-04       Impact factor: 6.016

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.